Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. The finding, by The University of Manchester, will facilitate ...
Jun 28, 2023
0
8
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found. The findings are published in the British Journal of General ...
Dec 15, 2022
0
2
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10
The federal government has been tracking industry payments from pharmaceutical and medical device companies to doctors since 2013, but last year was the first time such numbers were tracked for advanced practice clinicians.
Nov 4, 2022
0
12
Electronic cigarette companies will have four additional months to submit their products for government review because of delays tied to the coronavirus outbreak.
Apr 23, 2020
0
1
Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).
Nov 11, 2019
0
1
I am a graduate student and resident in the field of neurosurgery and would like to share an unusual and very personal story of developing a drug. Developmental biologist Dr. Matthew Scott and I went from purely basic biological ...
Dec 20, 2018
0
1
Another day, another announcement about a COVID-19 vaccine. Whether that's talk of results from clinical trials, emergency approval or plans for countries to prioritize certain groups for vaccination.
Dec 18, 2020
0
0
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high, the state's attorney general said Monday.
Jul 31, 2019
0
0
